Specialty Pharmacy Times
December 2012
Volume: 3
Issue: 6
October 2012
Volume: 3
Issue: 5
August 2012
Volume: 3
Issue: 4
June 2012
Volume: 3
Issue: 3
April 2012
Volume: 3
Issue: 2
February 2012
Volume: 3
Issue: 1
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ramantamig's 93.6% ORR and Outpatient CRS Control
2
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
3
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
4
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
5